As of September 22, 2025, Denali Capital Acquisition Corp. was acquired by Semnur Pharmaceuticals, Inc., in a reverse merger transaction. Denali Capital Acquisition Corp. does not have significant operations. It intends to affect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses in technology, consumer, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.